Karl Quint

Clinical significance of histone deacetylases 1, 2, 3, and 7: HDAC2 is an independent predictor of survival in HCC

Karl Quint, Abbas Agaimy, Pietro Di Fazio et al. · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · 2011 · 114 citations

Histone Modifications, Cancer Research, Chromatin +13

Pancreatic cancer cells surviving gemcitabine treatment express markers of stem cell differentiation and epithelial-mesenchymal transition

Karl Quint, Manuel Tonigold, Pietro Di Fazio et al. · International Journal of Oncology · 2012 · 80 citations · Full text

Downregulation of HMGA2 by the pan-deacetylase inhibitor panobinostat is dependent on hsa-let-7b expression in liver cancer cell lines

Pietro Di Fazio, Roberta Montalbano, Daniel Neureiter et al. · Experimental Cell Research · 2012 · 73 citations

Tumor Biology, Pancreatic Cancer, Pan-deacetylase Inhibitor Panobinostat +8

Enhancement of the Antiproliferative Activity of Gemcitabine by Modulation of c-Met Pathway in Pancreatic Cancer

Amir Avan, Karl Quint, Francesco Nicolini et al. · Current Pharmaceutical Design · 2012 · 63 citations

Cda Expression, Chemoprevention Strategy, Tumor Biology +17

The Pan-Deacetylase Inhibitor Panobinostat Inhibits Growth of Hepatocellular Carcinoma Models by Alternative Pathways of Apoptosis

Pietro Di Fazio, Regine Schneider‐Stock, Daniel Neureiter et al. · SHILAP Revista de lepidopterología · 2010 · 61 citations · Full text